A carregar...

Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis

Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC). We conducted this systematic review and meta-analysis to assess whether blood can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Mao, Chen, Yuan, Jin-Qiu, Yang, Zu-Yao, Fu, Xiao-Hong, Wu, Xin-Yin, Tang, Jin-Ling
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616411/
https://ncbi.nlm.nih.gov/pubmed/26020382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!